These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 30537561

  • 61. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.
    Didier A, Melac M, Montagut A, Lhéritier-Barrand M, Tabar A, Worm M.
    Allergy; 2009 Jan; 64(1):166-71. PubMed ID: 19076546
    [Abstract] [Full Text] [Related]

  • 62. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE SECOND TREATED YEAR FOR 133 PATIENTS WITH JAPANESE CEDAR POLLINOSIS IN 2016].
    Yuta A, Ogawa Y, Suzuki Y, Arikata M, Kozaki H, Shimizu T, Ohta N.
    Arerugi; 2016 Jan; 65(9):1209-1218. PubMed ID: 27885205
    [Abstract] [Full Text] [Related]

  • 63. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis.
    Bozek A, Kolodziejczyk K, Warkocka-Szoltysek B, Jarzab J.
    Am J Rhinol Allergy; 2014 Jan; 28(5):423-7. PubMed ID: 25198030
    [Abstract] [Full Text] [Related]

  • 64. A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
    Murphy K, Gawchik S, Bernstein D, Andersen J, Pedersen MR.
    J Negat Results Biomed; 2013 Jun 01; 12():10. PubMed ID: 23725348
    [Abstract] [Full Text] [Related]

  • 65. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.
    Clin Ther; 2011 Jul 01; 33(7):828-40. PubMed ID: 21741092
    [Abstract] [Full Text] [Related]

  • 66. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.
    Valovirta E, Petersen TH, Piotrowska T, Laursen MK, Andersen JS, Sørensen HF, Klink R, GAP investigators.
    J Allergy Clin Immunol; 2018 Feb 01; 141(2):529-538.e13. PubMed ID: 28689794
    [Abstract] [Full Text] [Related]

  • 67. Long-term sublingual immunotherapy for Japanese cedar pollinosis and the levels of IL-17A and complement components 3a and 5a.
    Sakashita M, Yamada T, Imoto Y, Hirota T, Tamari M, Ito Y, Kubo S, Osawa Y, Takahashi N, Fujieda S.
    Cytokine; 2015 Sep 01; 75(1):181-5. PubMed ID: 25934649
    [Abstract] [Full Text] [Related]

  • 68. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
    Ueda S, Ito J, Harada N, Harada S, Sasano H, Sandhu Y, Tanabe Y, Abe S, Shiota S, Kodama Y, Nagaoka T, Makino F, Chiba A, Akiba H, Atsuta R, Miyake S, Takahashi K.
    Biomolecules; 2022 Mar 29; 12(4):. PubMed ID: 35454107
    [Abstract] [Full Text] [Related]

  • 69. [ENHANCED CLINICAL EFFECTS OF CEDARCURE® TABLETS OF SUBLINGUAL IMMUNOTHERAPY OVER THE YEARS OF TREATMENT AND THE IMPACT OF OUTCOME BY COMBINED USE OF MITE SUBLINGUAL IMMUNOTHERAPY (DUAL SLIT) FOR JAPANESE CEDAR POLLINOSIS].
    Yuta A, Ogawa Y, Murao T, Kozaki H, Shimizu T.
    Arerugi; 2022 Mar 29; 71(9):1122-1128. PubMed ID: 36372423
    [Abstract] [Full Text] [Related]

  • 70. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H.
    Allergy; 2009 Jan 29; 64(1):179-86. PubMed ID: 19076534
    [Abstract] [Full Text] [Related]

  • 71. [CLINICAL EFFICACY OF 69 PATIENTS WITH JAPANESE CEDAR POLLINOSIS TREATED BY SUBLINGUAL IMMUNOTHERAPY WITH CEDARCURE® IN THE FIRST FOLLOW-UP YEAR].
    Yuta A, Ogawa Y, Suzuki Y, Ogihara H, Kozaki H, Shimizu T.
    Arerugi; 2019 Jan 29; 68(8):958-965. PubMed ID: 31534107
    [Abstract] [Full Text] [Related]

  • 72. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
    Durham SR, Creticos PS, Nelson HS, Li Z, Kaur A, Meltzer EO, Nolte H.
    J Allergy Clin Immunol; 2016 Oct 29; 138(4):1081-1088.e4. PubMed ID: 27527264
    [Abstract] [Full Text] [Related]

  • 73. Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents.
    Halken S, Agertoft L, Seidenberg J, Bauer CP, Payot F, Martin-Muñoz MF, Bartkowiak-Emeryk M, Vereda A, Jean-Alphonse S, Melac M, Le Gall M, Wahn U.
    Pediatr Allergy Immunol; 2010 Sep 29; 21(6):970-6. PubMed ID: 20718927
    [Abstract] [Full Text] [Related]

  • 74. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
    Valovirta E, Jacobsen L, Ljørring C, Koivikko A, Savolainen J.
    Allergy; 2006 Oct 29; 61(10):1177-83. PubMed ID: 16942565
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P, Wahn U, Zielen S, Heinrich J.
    Expert Rev Clin Immunol; 2017 Dec 29; 13(12):1199-1206. PubMed ID: 29072507
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets.
    Malling HJ, Lund L, Ipsen H, Poulsen L.
    J Investig Allergol Clin Immunol; 2006 Dec 29; 16(3):162-8. PubMed ID: 16784009
    [Abstract] [Full Text] [Related]

  • 79. 300IR 5-Grass pollen sublingual tablet offers relief from nasal symptoms in patients with allergic rhinitis.
    Serrano E, Wahn HU, Didier A, Bachert C.
    Am J Rhinol Allergy; 2014 Dec 29; 28(6):471-6. PubMed ID: 25335122
    [Abstract] [Full Text] [Related]

  • 80. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops and sublingual tablets) versus placebo in seasonal rhinitis.
    Pradalier A, Basset D, Claudel A, Couturier P, Wessel F, Galvain S, André C.
    Allergy; 1999 Aug 29; 54(8):819-28. PubMed ID: 10485385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.